Nuclear Medicine
AMMONIUM
Name:
Myocardiopet Radiofarma
Active Principle:
13N-Ammonium Chloride
Therapeutic Action:
It is indicated for the evaluation of myocardial perfusion in patients with suspected or existing coronary artery disease. It allows calculating the coronary reserve, diagnosing infective endocarditis, vasculitis, cardiac sarcoidosis and infection in pacemaker implants.
Nuclear Medicine
AMMONIUM
Name:
Myocardiopet Radiofarma
Active Principle:
13N-Ammonium Chloride
Therapeutic Action:
It is indicated for the evaluation of myocardial perfusion in patients with suspected or existing coronary artery disease. It allows calculating the coronary reserve, diagnosing infective endocarditis, vasculitis, cardiac sarcoidosis and infection in pacemaker implants.
RELATED PRODUCTS
-
AV45 (R+D)
AV45 (R+D)It is indicated for estimating the density of β-amyloid neuritic plaque in the brain of adult patients with cognitive impairment who are being evaluated for Alzheimer's disease and other causes of cognitive... -
177Lu DOTATATE (I+D)
177Lu DOTATATE (I+D)It is a radiolabeled somatostatin analog indicated for: - The treatment of gastroenteropancreatic tumors positive for the somatostatin receptor. Neuroendocrine tumors (GEP-NETs), including the foregut... -
PSMA (R+D)
PSMA (R+D)It is indicated for the detection and evaluation of prostate cancer from the initial diagnosis to the monitoring of castration-resistant metastases.